Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Materials (Basel) ; 17(8)2024 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-38673170

RESUMO

The recycling of fly ash from municipal solid waste incineration is currently a global issue. This work intends to examine the viability of a novel recycling alternative for fly ashes as a component of fire-resistant plates. To lessen the quantity of heavy metal leaching, the fly ash was utilized after being washed using a water/fly ash ratio of 2 for one hour. Subsequently, an inexpensive, straightforward molding and curing process was used to create a plate, with a composition of 60%wt of MSWI-FA, 30%wt of gypsum, 0.5%wt of glass fiber and 9.5%wt of vermiculite. The plate exhibited high fire resistance. Furthermore, it demonstrated compression, flexural strength and surface hardness slightly lower than the requirements of European Standards. This allows for manufacturing plates with a high washed MSWI-FA content as fire protection in firewalls and doors for homes and commercial buildings. A Life Cycle Assessment was carried out. The case study shows that a 60% substitution of gypsum resulted in an environmental impact reduction of 8-48% for all impact categories examined, except four categories impacts (marine eutrophication, human toxicity (cancer), human non-carcinogenic toxicity and water depletion, where it increased between 2 and 718 times), due to the previous washing of MSWI-FA. When these fly ashes are used as a raw material in fire-resistant materials, they may be recycled and offer environmental advantages over more conventional materials like gypsum.

2.
Appl Microbiol Biotechnol ; 107(5-6): 1947-1957, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36723703

RESUMO

The use of egg yolk antibodies-IgY technology-represents an alternative to the production of mammalian immunoglobulins and has several advantages regarding animal welfare and lower costs of production. The use of adjuvants to achieve the hyperimmunization of laying hens plays a key role in the success of the production of high levels of the antibodies. In the present work, two different adjuvant systems (Freund's adjuvants and MontanideTM ISA 71 VG) were compared to produce IgY anti-Bothrops alternatus. For the first immunization, formalin-inactivated Salmonella was added to MontanideTM ISA 71 VG to emulate Freund's complete adjuvant which includes a mycobacteria antigen. After eight immunizations, IgY produced by using either adjuvant was able to neutralize the lethal activity of the venom in a mouse model, but differences were found regarding the recognition of components of the venom between the two adjuvants tested. Overall, MontanideTM adjuvant used in this work could be a good alternative choice to produce antibodies capable of neutralizing the lethality of complex antigens. This adjuvant is commercially available and used in the formulation of several poultry vaccines and could be used for the IgY technology instead of traditional immunomodulators such as Freund's adjuvants. Key points • IgY extracts recognized major components of the venom.• Avidity indexes of the IgY extracts increased after the successive immunizations.• IgY obtained by two adjuvant systems neutralized the lethal activity of the venom.


Assuntos
Anticorpos Neutralizantes , Peçonhas , Camundongos , Animais , Feminino , Gema de Ovo , Galinhas , Adjuvantes Imunológicos , Adjuvante de Freund , Imunoglobulinas , Adjuvantes Farmacêuticos , Mamíferos
3.
Artigo em Inglês | MEDLINE | ID: mdl-36219924

RESUMO

Although mammals are still the main source of polyclonal antibodies production, the use of egg yolk immunoglobulins (IgY) is increasing, and thus improvement of its safety to reduce undesired reactions is needed. Removal of IgY constant domains by pepsin enzymatic treatment is expected to reduce potential adverse effects derived from the parenteral administration of these antibodies, while also increasing its distribution volume. Current Fab' production requires the previous purification of IgY to be used as starting material. In this context, relevant economic benefits may be gained if initial IgY purification could be avoided, by using rawer starting materials. In this work, a three-step process for Fab' production from crude egg yolk water-soluble fractions is described using scalable and simple low-cost technologies such as ultrafiltration and anion exchange chromatography. The overall process yield of 33% highly pure Fab' from water-soluble fractions favorably compares to the manufacture of related medicinal products from mammalian antibodies, such as antivenoms.


Assuntos
Gema de Ovo , Fragmentos Fab das Imunoglobulinas , Animais , Água , Galinhas , Imunoglobulinas , Anticorpos , Mamíferos
4.
Clin Infect Dis ; 72(10): e476-e483, 2021 05 18.
Artigo em Inglês | MEDLINE | ID: mdl-32803236

RESUMO

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused substantial morbidity and mortality worldwide. Few reports exist in Latin America, a current epicenter of transmission. Here, we aim to describe the epidemiology and outcomes associated with coronavirus disease 2019 (COVID-19) in Honduras. METHODS: Baseline clinical and epidemiological information of SARS-CoV-2 reverse transcriptase polymerase chain reaction-confirmed cases detected between 17 March-4 May in the San Pedro Sula Metropolitan area was collected; for hospitalized cases, clinical data were abstracted. Logistic regression models were fit to determine the factors associated with hospitalization. RESULTS: We identified 877 COVID-19 cases, of which 25% (n = 220) were hospitalized. The 19-44-year age group (57.8%) and males (61.3%) were predominant in overall COVID-19 cases. Of the cases, 34% (n = 299) had at least 1 preexisting medical condition. Individuals aged 45-69 years (adjusted odds ratio [aOR] = 4.05; 95% confidence interval [CI], 2.85-5.76) or ≥70 years (aOR = 9.12; 95% CI, 5.24-15.86), of male sex (aOR = 1.72; 95% CI, 1.21-2.44), and those with a preexisting condition (aOR = 2.12; 95% CI, 1.43-3.14) had higher odds of hospitalization. Of inpatients, 50% were hospitalized more than 7 days. The median length of hospitalization was 13 days (interquartile range [IQR], 8-29) among individuals aged 19-44 years, and 17 days (IQR, 11-24.6) among those aged 45-69. Of the fatal cases, 42% occurred among adults under 60 years old. CONCLUSIONS: Our findings show that a high proportion of COVID-19 cases in Honduras occurred among younger adults, who also constituted a significant proportion of severe and fatal cases. Preexisting conditions were associated with severe outcomes independently from age and were highly prevalent in Honduran COVID-19 cases.


Assuntos
COVID-19 , Adulto , Idoso , Honduras/epidemiologia , Hospitalização , Humanos , Masculino , Pessoa de Meia-Idade , Pandemias , Reação em Cadeia da Polimerase Via Transcriptase Reversa , SARS-CoV-2 , Adulto Jovem
5.
Rev. gastroenterol. Perú ; 30(4): 350-356, oct.-dic. 2010. ilus
Artigo em Espanhol | LILACS, LIPECS | ID: lil-576333

RESUMO

El artículo revisa la experiencia única en el Perú de 10 años de trasplantes realizada por el departamento de trasplantes del Hospital Nacional Guillermo Almenara Irigoyen (HNGAI), describiendo la historia, resultados quirúrgicos en adultos y niños, retrasplantes, trasplantes combinados hígado-riñon, las diferentes complicaciones encontradas y toda la experiencia recogida en los 72 trasplantes realizados hasta la presentación de este artículo.


The article reviews the experience in 10 years of hepatic transplants performed by The Transplant Department of the National Hospital Guillermo Almenara Irigoyen (HNGAI), describing the history, surgical outcomes in adults and children, retransplantation, combined liver-kidney transplants, complications in 72 transplants performed at the time of submission of the article.


Assuntos
Humanos , Masculino , Feminino , Complicações Pós-Operatórias , Transplante de Fígado/classificação , Transplante de Fígado/métodos , Transplante de Rim , Peru
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA